Attached: the national medicine circulation industry development plan (2016-2020)
Medicine circulation industry is the national medical and health undertakings and an important part of the health industry, is an important industry of relationship between people's health and life safety. In order to adapt to China's economic and social development and "healthy China" strategy implementation and medical health system reform of the new situation, promoting the sustainable the sustainable development of the medicine circulation industry, ensuring drug supply and meet the demand of the people's growing health and constantly improve the level of people's health and quality of life, according to the law of the People's Republic of China on the 13th five-year plan for national economic and social development program, the "healthy China 2030" planning outline ", "business development thirteenth five-year plan outline and the domestic trade circulation" much starker choices-and graver consequences-in "development plan", this planning is formulated. Planning for 2016-2016.
A, the development present situation and the situation
(a) industry development present situation.
"Twelfth five-year" period, the enforcement of the medicine circulation industry planning, industry continued to strengthen infrastructure construction, and management system is increasingly perfect, the market mechanism function gradually increases, the industry presents the transformation development new situation.
Industry maintained steady and rapid growth. Held in 2015, the national pharmaceutical wholesale enterprises business certificate number of about 1.35 m, with the "11th five-year plan" at the end of the flat; Pharmaceutical retail chain enterprises 4981, a total of 44.8 retail pharmacies stores, 4.9 more than at the end of the period of "11th five-year plan", Has the Internet drug trading qualification of 517 enterprises.
Industry concentration degree enhances unceasingly. In 2015, pharmaceutical wholesale enterprises of sales of pharmaceutical wholesale market in the proportion of the total increase to 86% from 69% in 2010. Drug retail chain operation rate increased from 33% in 2010 to 46%; Form a three year sales of more than 100 billion yuan nationwide large-scale pharmaceutical circulation enterprises and 25 year sales of more than 10 billion yuan of regional medicine circulation enterprises, industry concentration improved significantly. Through the capital market financing of enterprises increased by 12, 2010 to 2010 in 20, mergers and reorganization of listed companies is active.
Industry gradually improve service ability. Release the pharmaceutical wholesale enterprises logistics service capability assessment indicators, "retail pharmacy business service specification" and so on a series of industry standards. Retail pharmacies licensed pharmacists with Numbers from 43000 at the end of the period of "11th five-year plan" to 218000 people, provide patients with a more professional help in time. "Twelfth five-year" personnel training plan formulation, the total training staff of more than 2000 people, strongly promote industry personnel quality improvement.
Industry social function. Medicine circulation industry not only to satisfy the more than 980000 medical and health institutions of the country's drug demand, every year through retail pharmacy services more than 130 people directly, in guarantee the drug supply, convenient masses to buy medicine, health service people plays an important role. In 2015, the industry employs about 5.34 million, accounting for 5% of the urban and rural employment in service industry. The rapid development of the pharmaceutical logistics and medical exhibition economy, led equipment manufacturing, information technology, software development, development of related industries, such as accommodation catering.
At the same time, the industry development, there are some outstanding problems: one is the unreasonable industry structure. Pharmaceutical wholesale enterprises supply capacity is greater than demand on the whole, and in some remote areas drug supply is obviously insufficient; Pharmaceutical retail enterprise is small, scattered problems still outstanding; Industry concentration and the rate of drug retail chain operation remains to be further improved. The second is the circulation modernization level is not high. Modern medicine logistics technology has not been widely adopted, the circulation cost is higher; The lack of storage facilities, modern traditional Chinese medicinal materials circulation circulation way behind; Supply chain management and informationization level is not high. Three is industry service ability is insufficient. Enterprise customer-focused business philosophy to ascend; Part of the enterprise management is not standard, lack of brand competitiveness; Pharmaceutical technical personnel lack of professional service ability is weak, industry service great health function into full play.
(2) the situation facing the development of industry.
"Much starker choices-and graver consequences-in" period is to build a well-off society in an all-round way and carry out the strategic target of "healthy China" important stage, is to realize the medical and health system reform goal and the key to the development of medicine circulation industry transition period, the medicine circulation industry faces new opportunities and challenges.
Medicine and health service market demand growing. In the next five years, with the acceleration of urbanization in China, population aging speed up, two child policy open, the steady growth of income, people's demand for medical and health services and self care will increase dramatically, drugs, health products and health services market size will speed up growth.
Medical and health system reform continues to advance. Along with the reform of public hospitals, health care payment system reform and the hierarchical diagnosis and treatment, health care will increase steadily in our country, medical security level will gradually increase, thus greatly expand the medicine circulation industry development space.
Transformation and upgrading of drug circulation demand more urgent. From the point of their own, medicine circulation industry need to quickly adapt to new forms, new model of flow change, effectively meet the requirements of medical and health system reform and the people's growing health needs. From the point of the external environment, the "two votes", "medicine to separate" the implementation of the policy and "Internet + medicine" and so on the mode of innovation, industry transformation and upgrading of new requirements are put forward.
Second, the guiding ideology and the overall goals
(a) the guiding ideology.
Fully implement the party's 18 large and 18 sixth plenary session of 3, 4, 5, spirit, in-depth study and implement general secretary xi series of important speech spirit, closely around as a whole to promote "five one" the overall layout and coordination to promote "comprehensive" four strategic layout, firmly set up and implement the new concept of development, in order to improve the level of the people's health as the core, driven by reform and innovation, to create a modern medicine circulation system as the goal, to promote transformation and upgrading of industries as the main line, with circulation of informatization, standardization and intensive direction, to improve the environment for industry development, actively promote the reform of medicine circulation industry supply side structural, give full play to its service function of medical health care and health industry.
(2) the overall goals.
By 2020, basic medicine circulation industry development to adapt to build a well-off society in an all-round way of the overall goal and the people's growing health needs, forming a unified open, competitive and orderly, centering on network layout optimization, high efficiency, safety, convenience and circulation, the masses benefit from modern medicine circulation system.
Specific goal: cultivating formed a group of network covering the whole country, intensive and informatization degree higher large medicine circulation enterprises. Pharmaceutical wholesale enterprises with annual sales accounted for more than 90% of the total pharmaceutical wholesale market; Pharmaceutical retail enterprises with annual sales accounted for over 40% of the total amount of medicine retail market; Rate of drug retail chain of more than 50%.
Three, the main task
(a) reasonable planning industry layout, improve the drug distribution network.
Guiding the efficient allocation of resources. According to the medical and health undertakings development needs, according to the region's economic and social development level, urban and rural construction and development planning, the structure of the population and actual situation, in conjunction with the departments issuing annual number of drug consumption, medicine circulation enterprises, warehousing logistics capability, information such as coverage rates of retail pharmacies, guide the medicine circulation efficient allocation of resources. Cooperate with related department to optimize pharmaceutical logistics, retail enterprise network layout, network layout and regional development adapted to match, the drug supply and drug demand, avoid the repetitive construction and disorderly competition.
Build in urban and rural distribution network. Actively adapt to the reform of the "two votes" requirements, and gradually build large-scale backbone enterprise as the main body, small and medium enterprises as necessary complement modern medicine circulation network. Support strength, management norms, high credibility of the national and regional medicine circulation backbone enterprises, focus on the weak area of the logistics capability, integration, transformation and new has certain radiation ability of pharmaceutical logistics distribution center. Encourage large and medium-sized pharmaceutical wholesale enterprises, retail chain enterprises mainly for the convenience of business circle in the city, the new communities, rural and remote areas extend distribution and service network, giving full play to the advantages of postal enterprises, express delivery companies deliver network, realize effective covering of medicine circulation to the grassroots. To encourage small and medium-sized pharmaceutical circulation enterprises to develop specialization, characterization, doing fine designed, meet the multi-level market demand.
Enhance industry concentration. Encourage medicine circulation enterprises through merger and reorganization, the listed financing, issuing bonds and other way to do strong, do big, speed up the implementation scale, intensive and modern management. Support the development of small and medium-sized pharmaceutical circulation enterprises procurement alliance and pharmacy alliance, using 聯購 distribution, unified distribution, reduce operating costs, improve the organizational level. Encourage a zero integration, chaining operation, development of multiple formats of mixed operation.
(2) improve circulation management level, make modern medical providers.
Optimization of drug supply chain management. Support medicine circulation enterprises to strengthen supply chain management, improve the supply chain integration system, to provide supply chain upstream and downstream market development, price negotiation, online payment, financial support and other value-added services and integrated solutions, accelerate the development of transforming to pharmaceutical supply chain service provider. Use of cloud computing, big data and other modern information technology, integration of drug research and development production, circulation use, disease changes and patients' health demand and consumption habits of data information, strengthen the management of big data, analysis and application, for drug research and development institutions, judge the trend of the market, adjust the product structure and production enterprise medical institutions to improve drug choice, strengthen the rational use of drugs, to provide valuable data to support, improve the operation efficiency of the whole supply chain.
The development of modern green medicine logistics. Support drug circulation enterprises to promote the use of radio frequency identification, automatic sorting conveyor, satellite positioning and other advanced logistics technology, the development of upstream and downstream supply chain to connect, warehousing and transport resources effectively integrate, more collaborative distribution, a new type of modern green logistics cost economy pharmaceutical logistics. Support pharmaceutical cold-chain logistics system, encourage through collaborative logistics, joint distribution, realize the cold chain between enterprises resource sharing of the Internet. Construction in raw packaging, storage and maintenance, logistics distribution and traceability management in the integration of traditional Chinese medicine modern logistics system, improve the level of logistics organization, standardization and modernization of traditional Chinese medicinal materials. Promote the implementation of urban distribution vehicle unified identity management, convenient drug delivery vehicles.
(3) the business model innovation industry, expanding industry service function.
Promote the "Internet + medicine circulation". To promote information technology such as mobile Internet, Internet of things is widely used in the field of drug circulation, encourage enterprises to carry out the service innovation based on the Internet, the drug circulation channel and development pattern. Support drug distribution enterprises and medical institutions and health care department, e-commerce enterprises to carry out the medical electrical business services, provide patients with over-the-counter "net book (medicine) shop", "net book (medicine) shop" and convenient services, promote the development of online fusion.
Retail service mode innovation. In retail pharmacy information system and information system of medical institutions and medical insurance payment system docking process, encourage qualified retail pharmacies to undertake outpatient pharmacy service of medical institutions and other professional services. Guide the build system of chief pharmacist, with an emphasis on antimicrobial agents to guide rational drug use, and strive to improve the drug quality management of pharmaceutical service level. Positive publicity and reasonable application of antimicrobial drugs knowledge, improve the public awareness of the bacterial drug resistance crisis. Encourage the application of new technologies, such as wearable medical, doctors, dietitians, health management division, nurses and other professional talent, actively develop personal health management, disease prevention and slow management business, to build "service + product" new formats. Support the development of professional pharmacy, medicine (beauty) makeup shop, "pharmacy + clinic, the doctor of traditional Chinese medicine (national physician) the new retail such as mode of operation, advocate one-stop service and personalized service. Promote medical combination, encourage and medical and health institutions, community endowment institutions and domestic service agencies to provide for the aged home pension and health care services.
To develop intermediary services. Cultivating market intermediaries, encourages related to medical treatment, medicine market research, management consulting, price monitoring, evaluation and protection of intellectual property rights, information technology support and other intermediary services. Encouraged to provide pharmaceutical sales channels, the consumption structure and regional distribution of information services, such as traditional Chinese and western medicine, Chinese medicine yinpian and traditional Chinese medicine key varieties of market operation monitoring and early warning service. Encouraged to build all kinds of industry information service platform, promote industry information exchange and sharing.
(4) "introduced to" and "going out", the combination of enhance the opening industry level.
Improve the utilization of foreign capital industry. To attract overseas drug distribution enterprises shall, in accordance with the relevant policies to expand domestic investment, to participate in domestic mergers and reorganization. Encourage domestic enterprises with the world's leading multinational enterprises set up joint venture company, to learn from foreign counterparts of advanced enterprise management idea and experience, all-round optimization operation mode, management mode and technology, improving the quality of private brand and core competence.
Support the development of foreign enterprises. Support medicine circulation enterprises to carry out various forms of international exchanges and cooperation, participate in the pharmaceutical supply chain of international division of labor, enhance the level of internationalization. Service country "area" strategy, and actively develop "neighbourhood" all the way along the national pharmaceutical market, to carry out medical investment cooperation with relevant countries. Give full play to the medicine, the role of exhibition economy in exploring international market, promote the international domestic enterprise visibility and reputation. To build international cooperation platform, and actively participate in global public health aid. Promote the establishment of international standards and certification system of traditional Chinese medicine, to expand international market access of Chinese medicine through multilateral negotiation. Vigorously develop trade in services of traditional Chinese medicine to cure with medicine, expanding the size of the market of traditional Chinese medicine in our country, improve the international influence of Chinese medicine.
(5) to strengthen the construction of industry base, improve the ability of service industry.
Improving the industry standard system. Guide the medicine circulation industry association industry standard is scientific, advanced and forward-looking, to further improve the industry management and service standards. The interaction between drug circulation encoding rules or electronic data specification, gradually achieve efficient drug circulation and full traceability. For retail pharmacies classification management system, to carry out the retail pharmacy management service capability classification evaluation. Product specifications and grades for commonly used standards and traditional Chinese medicine packaging, storage, maintenance, back and other related standards. By conducting standard propaganda training, logo licensing, implementation of supervision work, guide the medicine circulation enterprises to carry out industry standards.
Improving the quality of industrial statistic work. According to a new dynamic and new trend in the development of industry, adjust industry statistical indicator system, improve the system of statistics. We will further expand coverage for industrial statistic work, to include more companies direct quote system, improve the comprehensiveness and accuracy of statistics. Further shorten industry statistics feedback cycle, improve the timeliness of statistics. Timely optimization data submitted to the system, strengthen the industry statistics personnel training. Further strengthen the industry statistics analysis and the application work, fully tap the intrinsic value of the data information and gradually achieve statistical information sharing between the industry and the relevant departments.
Strengthen the theory research and personnel training. Organized medicine circulation industry associations, universities and colleges, scientific research institutions, intermediary institutions and enterprises to carry out the medicine circulation industry major research subjects, strengthen the intelligent medical services, medicine, medicine circulation theory research in aspects of electronic commerce. Encourage the industry association and social training institutions to carry out vocational training and international training, form the multi-level personnel training system. More professional, senior talents cultivation and introduction, optimize enterprise senior management team. To strengthen supply chain management, modern logistics, pharmaceutical care, health management and other professional talents education, accumulated reserve of human resources in the development of industry.
Strengthen enterprise management ability. Encourage medicine circulation enterprises to strengthen internal management, set up information complete drug purchasing records, positive drug procurement bill management standardization, electronic. Strictly implement on prescription sales of antimicrobial agents, in order to strengthen the management of drug effect and packaging materials, specifications expired drugs such as abandoned drugs and its disposal of packaging materials. Improve enterprise's safety management system, to carry out the safe production responsibility, thoroughly screening potential safety problems and weak links, effectively prevent contain safety accidents. To establish drug (Chinese medicine) information tracing system, to improve enterprise management ability. Combined with the transformation and upgrading of organization structure change, the quality of service standards, set up service level evaluation and examination system, forming self motivation mechanism. Support to carry out the brand construction, the implementation of brand strategy, and strive to build brand enterprises, brand pharmacy. Encourage old pharmacy on the basis of traditional advantage, to further expand the brand influence.
The previous page [1] [2] [3] The next page
|
